264 related articles for article (PubMed ID: 22494015)
1. Water-soluble iron oxide nanocubes with high values of specific absorption rate for cancer cell hyperthermia treatment.
Guardia P; Di Corato R; Lartigue L; Wilhelm C; Espinosa A; Garcia-Hernandez M; Gazeau F; Manna L; Pellegrino T
ACS Nano; 2012 Apr; 6(4):3080-91. PubMed ID: 22494015
[TBL] [Abstract][Full Text] [Related]
2. Mesoscale assemblies of iron oxide nanocubes as heat mediators and image contrast agents.
Materia ME; Guardia P; Sathya A; Leal MP; Marotta R; Di Corato R; Pellegrino T
Langmuir; 2015 Jan; 31(2):808-16. PubMed ID: 25569814
[TBL] [Abstract][Full Text] [Related]
3. Preparation of carboplatin-Fe@C-loaded chitosan nanoparticles and study on hyperthermia combined with pharmacotherapy for liver cancer.
Li FR; Yan WH; Guo YH; Qi H; Zhou HX
Int J Hyperthermia; 2009 Aug; 25(5):383-91. PubMed ID: 19391033
[TBL] [Abstract][Full Text] [Related]
4. Preparation of magnetic iron oxide nanoparticles for hyperthermia of cancer in a FeCl₂-NaNO₃-NaOH aqueous system.
Li Z; Kawashita M; Araki N; Mitsumori M; Hiraoka M; Doi M
J Biomater Appl; 2011 Mar; 25(7):643-61. PubMed ID: 20207773
[TBL] [Abstract][Full Text] [Related]
5. Asymmetric Assembling of Iron Oxide Nanocubes for Improving Magnetic Hyperthermia Performance.
Niculaes D; Lak A; Anyfantis GC; Marras S; Laslett O; Avugadda SK; Cassani M; Serantes D; Hovorka O; Chantrell R; Pellegrino T
ACS Nano; 2017 Dec; 11(12):12121-12133. PubMed ID: 29155560
[TBL] [Abstract][Full Text] [Related]
6. Water-dispersible sugar-coated iron oxide nanoparticles. An evaluation of their relaxometric and magnetic hyperthermia properties.
Lartigue L; Innocenti C; Kalaivani T; Awwad A; Sanchez Duque Mdel M; Guari Y; Larionova J; Guérin C; Montero JL; Barragan-Montero V; Arosio P; Lascialfari A; Gatteschi D; Sangregorio C
J Am Chem Soc; 2011 Jul; 133(27):10459-72. PubMed ID: 21604803
[TBL] [Abstract][Full Text] [Related]
7. Confining Iron Oxide Nanocubes inside Submicrometric Cavities as a Key Strategy To Preserve Magnetic Heat Losses in an Intracellular Environment.
Zyuzin MV; Cassani M; Barthel MJ; Gavilan H; Silvestri N; Escudero A; Scarpellini A; Lucchesi F; Teran FJ; Parak WJ; Pellegrino T
ACS Appl Mater Interfaces; 2019 Nov; 11(45):41957-41971. PubMed ID: 31584801
[TBL] [Abstract][Full Text] [Related]
8. Properties of nanoparticles prepared from NdFeB-based compound for magnetic hyperthermia application.
Périgo EA; Silva SC; de Sousa EM; Freitas AA; Cohen R; Nagamine LC; Takiishi H; Landgraf FJ
Nanotechnology; 2012 May; 23(17):175704. PubMed ID: 22481311
[TBL] [Abstract][Full Text] [Related]
9. Size-sorted anionic iron oxide nanomagnets as colloidal mediators for magnetic hyperthermia.
Fortin JP; Wilhelm C; Servais J; Ménager C; Bacri JC; Gazeau F
J Am Chem Soc; 2007 Mar; 129(9):2628-35. PubMed ID: 17266310
[TBL] [Abstract][Full Text] [Related]
10. Growth and characterization of iron oxide nanorods/nanobelts prepared by a simple iron-water reaction.
Zhao YM; Li YH; Ma RZ; Roe MJ; McCartney DG; Zhu YQ
Small; 2006 Mar; 2(3):422-7. PubMed ID: 17193062
[TBL] [Abstract][Full Text] [Related]
11. High-frequency, magnetic-field-responsive drug release from magnetic nanoparticle/organic hybrid based on hyperthermic effect.
Hayashi K; Ono K; Suzuki H; Sawada M; Moriya M; Sakamoto W; Yogo T
ACS Appl Mater Interfaces; 2010 Jul; 2(7):1903-11. PubMed ID: 20568697
[TBL] [Abstract][Full Text] [Related]
12. Poly(ethylene glycol)-based magnetic hydrogel nanocomposites for hyperthermia cancer therapy.
Meenach SA; Hilt JZ; Anderson KW
Acta Biomater; 2010 Mar; 6(3):1039-46. PubMed ID: 19840875
[TBL] [Abstract][Full Text] [Related]
13. Iron oxide-based nanostructures for MRI and magnetic hyperthermia.
Hilger I; Kaiser WA
Nanomedicine (Lond); 2012 Sep; 7(9):1443-59. PubMed ID: 22994960
[TBL] [Abstract][Full Text] [Related]
14. Incorporation of Mg and Ca into nanostructured Fe2O3 improves Fe solubility in dilute acid and sensory characteristics in foods.
Hilty FM; Knijnenburg JT; Teleki A; Krumeich F; Hurrell RF; Pratsinis SE; Zimmermann MB
J Food Sci; 2011; 76(1):N2-10. PubMed ID: 21535701
[TBL] [Abstract][Full Text] [Related]
15. Thermoresponsive core-shell magnetic nanoparticles for combined modalities of cancer therapy.
Purushotham S; Chang PE; Rumpel H; Kee IH; Ng RT; Chow PK; Tan CK; Ramanujan RV
Nanotechnology; 2009 Jul; 20(30):305101. PubMed ID: 19581698
[TBL] [Abstract][Full Text] [Related]
16. Glycine passivated Fe3O4 nanoparticles for thermal therapy.
Barick KC; Hassan PA
J Colloid Interface Sci; 2012 Mar; 369(1):96-102. PubMed ID: 22209576
[TBL] [Abstract][Full Text] [Related]
17. Clinical hyperthermia of prostate cancer using magnetic nanoparticles: presentation of a new interstitial technique.
Johannsen M; Gneveckow U; Eckelt L; Feussner A; Waldöfner N; Scholz R; Deger S; Wust P; Loening SA; Jordan A
Int J Hyperthermia; 2005 Nov; 21(7):637-47. PubMed ID: 16304715
[TBL] [Abstract][Full Text] [Related]
18. A smart platform for hyperthermia application in cancer treatment: cobalt-doped ferrite nanoparticles mineralized in human ferritin cages.
Fantechi E; Innocenti C; Zanardelli M; Fittipaldi M; Falvo E; Carbo M; Shullani V; Di Cesare Mannelli L; Ghelardini C; Ferretti AM; Ponti A; Sangregorio C; Ceci P
ACS Nano; 2014 May; 8(5):4705-19. PubMed ID: 24689973
[TBL] [Abstract][Full Text] [Related]
19. Ultrasmall water-soluble metal-iron oxide nanoparticles as T1-weighted contrast agents for magnetic resonance imaging.
Zeng L; Ren W; Zheng J; Cui P; Wu A
Phys Chem Chem Phys; 2012 Feb; 14(8):2631-6. PubMed ID: 22273844
[TBL] [Abstract][Full Text] [Related]
20. Magnetic SiO2 gel microspheres for arterial embolization hyperthermia.
Li Z; Kawashita M; Araki N; Mitsumori M; Hiraoka M; Doi M
Biomed Mater; 2010 Dec; 5(6):065010. PubMed ID: 21060148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
